Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
JPRN-jRCT2031260187 Tetanus toxoid reduced diphtheria toxoid and acellular pertussis vaccine adsorbe Diphtheria Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
JPRN-jRCT2031260187 Tetanus toxoid reduced diphtheria toxoid and acellular pertussis vaccine adsorbe Diphtheria Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
JPRN-jRCT2031260187 clinical trial report covering Tetanus toxoid reduced diphtheria toxoid and acellular pertussis vaccine adsorbe, Phase 3, endpoints, spons
Read →
NCT07623200 INCA-033989 Thrombocythemia, Essential Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07623200 INCA-033989 Thrombocythemia, Essential Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07623200 clinical trial report covering INCA-033989, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07624305 Balcinrenone/Dapagliflozin Chronic Kidney Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07624305 Balcinrenone/Dapagliflozin Chronic Kidney Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07624305 clinical trial report covering Balcinrenone/Dapagliflozin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07622810 Bofanglutide Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07622810 Bofanglutide Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07622810 clinical trial report covering Bofanglutide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07626437 Metamizole Sodium Common Cold Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07626437 Metamizole Sodium Common Cold Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07626437 clinical trial report covering Metamizole Sodium, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07625644 BL-M14D1 Extensive stage Small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07625644 BL-M14D1 Extensive stage Small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07625644 clinical trial report covering BL-M14D1, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07625280 Sodium Oxybate/Potassium Oxybate/Calcium Oxybate/Magnesium Oxybate Narcolepsy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07625280 Sodium Oxybate/Potassium Oxybate/Calcium Oxybate/Magnesium Oxybate Narcolepsy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07625280 clinical trial report covering Sodium Oxybate/Potassium Oxybate/Calcium Oxybate/Magnesium Oxybate, Phase 3, endpoints, sponsor, geography, readout
Read →
NCT07627906 Propofol/Ketamine Hydrochloride Emergence Delirium Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07627906 Propofol/Ketamine Hydrochloride Emergence Delirium Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07627906 clinical trial report covering Propofol/Ketamine Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space
Read →
NCT07625774 Safiglipron Chronic Kidney Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07625774 Safiglipron Chronic Kidney Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07625774 clinical trial report covering Safiglipron, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07626411 REGN-7508 Stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07626411 REGN-7508 Stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07626411 clinical trial report covering REGN-7508, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07625306 Pelacarsen Acute Coronary Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07625306 Pelacarsen Acute Coronary Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07625306 clinical trial report covering Pelacarsen, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07630779 Inositol Diabetes Mellitus Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07630779 Inositol Diabetes Mellitus Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07630779 clinical trial report covering Inositol, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →